HPV-16 and HLA-DRB1 Alleles Are Associated with Cervical Carcinoma in Mexican Mestizo Women

Archives of Medical Research

Volumn 42, Issue 5, 2011, Pages 421-425

  Alaez Verson, Carmen ^a   Berumen Campos, Jaime ^b,c   Munguía Saldaña, Andrea ^a   Flores Aguilar, Hilario ^a   Guardado Estrada, Mariano ^b,c   Rodríguez Gomez, Araceli ^a   Gorodezky Lauferman, Clara ^a  

^a Instituto Nacional de Diagnostico y Referencia Epidemiologicos   (Mexico)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Cervical cancer; DRB1 locus; HLA class II alleles; HPV 16; Mexican Mestizos; Susceptibility protection

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; PRIMER DNA; PROTEIN E6; PROTEIN E7; VIRUS DNA;

ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; LOW GRADE SQUAMOUS INTRAEPITHELIAL LESION; MAJOR CLINICAL STUDY; MEXICO; UTERINE CERVIX CARCINOMA; UTERINE CERVIX TUMOR;

ALLELES; DNA, VIRAL; ETHNIC GROUPS; FEMALE; HLA-DRB1 CHAINS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MEXICO; UTERINE CERVICAL NEOPLASMS;

EID: 80052736358     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2011.07.002     Document Type: Article

References (21)

1. Parkin D.M., Bray F., Ferlay J., et al. Global cancer statistics in the year 2002. CA Cancer J Clin 2005, 55:74-108.
2. http://www.dgepi.salud.gob.mx/anuario/html/anuarios.html.
3. Smith J.S., Lindsay L., Hoots B., et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007, 121:621-632.
4. Ferrera A., Olivo A., Alaez C., et al. HLA DQA1 and DQB1 loci in Honduran women with cervical dysplasia and invasive cervical carcinoma and their relationship to human papillomavirus infection. Hum Biol 1999, 71:367-379.
5. Schlecht N.F., Kulaga S., Robitaille J., et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001, 286:3106-3114.
6. Peng S., Trimble C., Wu L., et al. HLA-DQB1*02-restricted HPV-16 E7 peptide-specific CD4+ T-cell immune responses correlate with regression of HPV-16-associated high-grade squamous intraepithelial lesions. Clin Cancer Res 2007, 13:2479-2487.
7. Wank R., Thomssen C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature 1991, 352:723-725.
8. de Araujo Souza P.S., Villa L.L. Genetic susceptibility to infection with human papillomavirus and development of cervical cancer in women in Brazil. Mutat Res 2003, 544:375-383.
9. Apple R.J., Erlich H.A., Klitz W., et al. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet 1994, 6:157-162.
10. Apple R.J., Becker T.M., Wheeler C.M., et al. Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma. J Natl Cancer Inst 1995, 87:427-436.
11. Maciag P.C., Schlecht N.F., Souza P.S., et al. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women. Cancer Epidemiol Biomarkers Prev 2000, 9:1183-1191.
12. Silva B., Vargas-Alarcon G., Zuniga-Ramos J., et al. Genetic features of Mexican women predisposing to cancer of the uterine cervix. Hum Pathol 1999, 30:626-628.
13. Berumen J., Ordonez R.M., Lazcano E., et al. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 2001, 93:1325-1330.
14. Hernández-Avila M., Lazcano-Ponce E., Berumen-Campos J., et al. Human papillomavirus 16-18 infection and cervical cancer in Mexico: a case-control study. Arch Med Res 1997, 28:265-271.
15. Tang T, Fernandez-Viña M, Middleton D, et al. 13th IHWS Technology Joint Report. Typing for class II alleles with sequence specific oligonucleotide reagents: Primers and probes. In Immunobiology of the Human MHC. Proceedings of the 13th International Histocompatibility Workshop and Conference. JA Hansen, Ed. IHWS Press; 2006. pp. 255-294.
16. Weir B.S. Genetic data analysis II: Methods for discrete population genetic data 1996, Sinauer Associates, Sunderland, MA.
17. Odunsi K., Ganesan T. Motif analysis of HLA class II molecules that determine the HPV associated risk of cervical carcinogenesis. Int J Mol Med 2001, 8:405-412.
18. Gallagher K.M., Man S. Identification of HLA-DR1- and HLA-DR15-restricted human papillomavirus type 16 (HPV16) and HPV18 E6 epitopes recognized by CD4+ T cells from healthy young women. J Gen Virol 2007, 88:1470-1478.
19. Yang Y.C., Chang T.Y., Lee Y.J., et al. HLA-DRB1 alleles and cervical squamous cell carcinoma: experimental study and meta-analysis. Hum Immunol 2006, 67:331-340.
20. Schiff M.A., Apple R.J., Lin P., et al. HLA alleles and risk of cervical intraepithelial neoplasia among southwestern American Indian women. Hum Immunol 2005, 66:1050-1056.
21. Rudolf M.P., Fausch S.C., Da Silva D.M., et al. Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro. J Immunol 2001, 166:5917-5924.